Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Evusheld (formerly AZD7442) long-acting antibody combination authorised for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19
-
AstraZeneca and Ionis sign deal to develop and commercialise eplontersen
-
AstraZeneca reinforces leadership in breast cancer at SABCS 2021 with new data underscoring ambition to redefine cancer care
-
Lynparza granted Priority Review in the US for BRCA-mutated HER2-negative high-risk early breast cancer
-
AstraZeneca unveils The Discovery Centre (DISC) in Cambridge
-
New analyses of two AZD7442 COVID-19 Phase III trials in high-risk populations confirm robust efficacy and long-term prevention
-
Two billion doses of AstraZeneca’s COVID-19 vaccine supplied to countries across the world less than 12 months after first approval
-
AZD8601 EPICCURE Phase II trial demonstrated safety and tolerability in patients with heart failure
-
Year-to-date and Q3 2021 results
-
AstraZeneca advances ambition to redefine care for blood cancer at ASH 2021
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
